| Fry's Food & Drug Store #136 | |
| 4329 W Northern Ave, Glendale, Arizona 85301 | |
| (623) 931-3739 |
| Name | Fry's Food & Drug Store #136 |
|---|---|
| Organization Name | Smiths Food & Drug Centers Inc |
| Location | 4329 W Northern Ave, Glendale, Arizona 85301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (623) 931-3739 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A better approach to advanced illness, including fewer hospitalizations, could improve quality of life and satisfaction for the sickest patients -; and save $25 billion in annual health-care costs, according to Gundersen Health System.
Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.
Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.
US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.
› Verified 8 days ago
| NPI Number | 1538100326 |
| Organization Name | SMITHS FOOD & DRUG CENTERS INC |
| Doing Business As | FRYS FOOD AND DRUG |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4329 W Northern Ave, Glendale, AZ 85301 |
| Phone Number | 623-931-3739 |
News Archive
A better approach to advanced illness, including fewer hospitalizations, could improve quality of life and satisfaction for the sickest patients -; and save $25 billion in annual health-care costs, according to Gundersen Health System.
Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.
Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.
US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.
› Verified 8 days ago
News Archive
A better approach to advanced illness, including fewer hospitalizations, could improve quality of life and satisfaction for the sickest patients -; and save $25 billion in annual health-care costs, according to Gundersen Health System.
Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.
Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.
US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.
› Verified 8 days ago
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5159 W Thunderbird Rd, Glendale, Arizona 85306 Phone: (623) 972-8119 | |
Cvs Pharmacy #07872 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7499 W Bethany Home Rd, Glendale, Arizona 85303 Phone: (623) 247-4091 | |
Cvs Pharmacy #00017 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 18591 N 59th Ave, Glendale, Arizona 85308 Phone: (602) 789-0438 | |
Arizona Cvs Stores, L.l.c. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5125 W. Olive Avenue, Glendale, Arizona 85302 Phone: (623) 931-0882 | |
Cvs Pharmacy #16700 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9350 W Northern Ave, Glendale, Arizona 85305 Phone: (623) 877-3481 |